Advertisement
Revisions to the Special Supplemental Nutrition Program for Women

New WIC Food Options Improve Maternal, Birth Outcomes

0
Improvements in high-risk moms and babies seen with modest improvements in nutritional content
Reduced household income and high incarceration rates are associated with drug-related deaths

High Incarceration Rates Tied to More Drug-Related Deaths

0
Findings based on U.S. county-level data, independent of opioid prescription rates
Overall

About 12 Percent With Ankle Sprain Fill Opioid Prescriptions

0
Among opioid-naive patients, 8.4 percent of those who filled an initial opioid Rx had persistent use
Children and young adult patients with congenital heart disease have an increased risk for developing cancer

Risk for Cancer Higher in Those With Congenital Heart Disease

0
Twofold higher risk for cancer seen for children, young adults with congenital heart disease
Guidelines for the management and treatment of group B streptococcal disease in infants were published online July 8 in Pediatrics.

Guidance Updated for Managing Infants at Risk for Group B Strep

0
Risk assessment should consider infants born at ≥35 0/7 weeks and ≤34 6/7 weeks separately
Two new research papers

Two Algorithms Can ID Patients at Risk for HIV, PrEP Candidates

0
Algorithms use data from EHRs to identify candidates for preexposure prophylaxis
Significant changes in how kidney disease is treated in the United States are outlined in an executive order that was signed Wednesday by President Donald Trump.

President to Sign Order to Improve Kidney Disease Care

0
Goals include disease prevention, switch to at-home dialysis, early transplants
Galcanezumab can reduce the frequency of episodic cluster headache attacks

Galcanezumab Can Cut Frequency of Cluster Headache Attacks

0
Mean reduction in weekly frequency of cluster headache attacks greater with galcanezumab versus placebo
Among community-dwelling older persons

Mentally Stimulating Activities Lower Risk for Cognitive Decline

0
Activities included reading books, using computers, social or craft activities, and playing games
Two experimental Ebola treatments being used in the current outbreak in eastern Democratic Republic of the Congo have proved effective in laboratory tests with human cells

Lab Tests Show Experimental Ebola Treatments Effective

0
Remdesivir, ZMapp monoclonal antibodies both appear to block growth of the Ebola virus strain